European Companies Search Engine

European Union Transparency Register Eutr 29 Nov 2025 European Union Transparency Register

Overview

Text

EU Transparency Register Entry

Identification

  • Identification Code: 790576352506-25
  • Registration Date: 2024-01-17 05:39:51
  • Last Update Date: 2025-11-27 10:16:00

General Information

  • Name: SEQENS
  • Entity Form: Société par Actions Simplifiée
  • Website: www.seqens.com
  • Registration Category: Companies & groups
  • Interest Represented: Promotes their own interests or the collective interests of their members

Contact Information

Head Office

  • Address: 21 chemin de la Sauvegarde, 69130 Ecully, FRANCE
  • Phone: +33 0426991800

EU Office

  • Address: 21 chemin de la Sauvegarde, 69130 Ecully, FRANCE
  • Phone: +33 0426991800

Goals

SEQENS is a world leader in the development and production of active pharmaceutical ingredients, intermediates and specialty ingredients, with 16 production sites, 9 R&D centers and 3,000 employees on 3 continents. As an integrated player across the entire value chain - from raw materials to active ingredients and from R&D to industrialization - SEQENS offers a broad portfolio of active pharmaceutical ingredients, pharmaceutical intermediates and specialty ingredients, develops and industrializes the most complex molecules, and leverages its ability to innovate, develop and implement the best available technologies.

Levels of Interest

  • Global

EU Legislative Proposals and Communication Activities

Members

  • Members (25%): ?
  • Members (Total): 1.0
  • Members (FTE): 0.25
  • Information on Members:

European Parliament Accreditation

  • Accredited Number: 0

Interests

  • Competition
  • Energy
  • Environment
  • Public health

Structure

Financial Data

  • New Organisation: No

Closed Year (2024-01-01 to 2024-12-01)

  • Costs: €10,000 - €24,999
  • Grants: Not specified

Current Year

  • Intermediaries: Not specified
  • Grants: Not specified

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Seqens SAS, Écully, France.